- Home
- MYND vs ALGS Comparison
MYND vs ALGS Comparison
Compare MYND & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- ALGS
- Stock Information
- Founded
- MYND 1998
- ALGS 2018
- Country
- MYND United States
- ALGS United States
- Employees
- MYND N/A
- ALGS N/A
- Industry
- MYND Other Consumer Services
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- ALGS Health Care
- Exchange
- MYND Nasdaq
- ALGS Nasdaq
- Market Cap
- MYND 38.8M
- ALGS 32.4M
- IPO Year
- MYND 2017
- ALGS 2020
- Fundamental
- Price
- MYND $0.83
- ALGS $5.56
- Analyst Decision
- MYND
- ALGS Strong Buy
- Analyst Count
- MYND 0
- ALGS 1
- Target Price
- MYND N/A
- ALGS $70.00
- AVG Volume (30 Days)
- MYND 46.1K
- ALGS 152.4K
- Earning Date
- MYND 05-20-2025
- ALGS 05-06-2025
- Dividend Yield
- MYND N/A
- ALGS N/A
- EPS Growth
- MYND N/A
- ALGS N/A
- EPS
- MYND N/A
- ALGS N/A
- Revenue
- MYND $267,380,999.00
- ALGS $3,270,000.00
- Revenue This Year
- MYND N/A
- ALGS $583.52
- Revenue Next Year
- MYND N/A
- ALGS N/A
- P/E Ratio
- MYND N/A
- ALGS N/A
- Revenue Growth
- MYND N/A
- ALGS N/A
- 52 Week Low
- MYND $0.61
- ALGS $3.76
- 52 Week High
- MYND $3.89
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- MYND 52.30
- ALGS 46.04
- Support Level
- MYND $0.74
- ALGS $4.20
- Resistance Level
- MYND $0.92
- ALGS $6.45
- Average True Range (ATR)
- MYND 0.09
- ALGS 0.72
- MACD
- MYND 0.02
- ALGS 0.34
- Stochastic Oscillator
- MYND 46.43
- ALGS 60.44
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.